NanoViricides Has Received Approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of the Democratic Republic of Congo

SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today reported that it has received approval to Start Phase II Clinical Trial of ...
Security Boulevard

How do I ensure my Agentic AI systems are safe

What Are Non-Human Identities (NHIs) and Why Are They Crucial for Safe Agentic AI? Have you considered the growing importance of Non-Human Identities (NHIs), especially when it comes to safeguarding ...
Human Rights WatchOpinion

Recommendations on Next Steps for Comprehensive Justice for Syria

Assad, ending over 60 years of Baath party rule in Syria, the country’s authorities have an unprecedented opportunity to ...
Human Rights Watch

Principles for Implementing the Declaration on Explosive Weapons in Populated Areas

Principles for Implementing the Declaration on Explosive Weapons in Populated Areas,” introduces seven guiding principles to ...